LIWANLI Innovation Co Ltd (3054) - Total Liabilities

Latest as of June 2025: NT$32.86 Million TWD ≈ $1.04 Million USD

Based on the latest financial reports, LIWANLI Innovation Co Ltd (3054) has total liabilities worth NT$32.86 Million TWD (≈ $1.04 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset growth rate of LIWANLI Innovation Co Ltd to track the company's year-over-year net asset growth rate.

LIWANLI Innovation Co Ltd - Total Liabilities Trend (2003–2024)

This chart illustrates how LIWANLI Innovation Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See how much free cash does LIWANLI Innovation Co Ltd generate to measure how efficiently the company converts operating cash flow to free cash.

LIWANLI Innovation Co Ltd Competitors by Total Liabilities

The table below lists competitors of LIWANLI Innovation Co Ltd ranked by their total liabilities.

Company Country Total Liabilities
Stalexport Autostrady SA
WAR:STX
Poland zł392.33 Million
Land General Bhd
KLSE:3174
Malaysia RM644.36 Million
Pioneer Floating Rate Trust
NYSE:PHD
USA $66.83 Million
OM Holdings Ltd
KLSE:5298
Malaysia RM413.13 Million
Impiana Hotels Bhd
KLSE:7243
Malaysia RM192.70 Million
Chongkundang
KO:001630
Korea ₩755.22 Billion
Shanghai Huayi Group Corp Ltd B
SHG:900909
China $40.79 Billion
Harmony Electronics
TWO:8182
Taiwan NT$2.25 Billion

Liability Composition Analysis (2003–2024)

This chart breaks down LIWANLI Innovation Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see LIWANLI Innovation Co Ltd (3054) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 13.30 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.04 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.04 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how LIWANLI Innovation Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for LIWANLI Innovation Co Ltd (2003–2024)

The table below shows the annual total liabilities of LIWANLI Innovation Co Ltd from 2003 to 2024.

Year Total Liabilities Change
2024-12-31 NT$39.23 Million
≈ $1.24 Million
-22.56%
2023-12-31 NT$50.66 Million
≈ $1.60 Million
+24.88%
2022-12-31 NT$40.57 Million
≈ $1.28 Million
-19.47%
2021-12-31 NT$50.38 Million
≈ $1.59 Million
-25.17%
2020-12-31 NT$67.32 Million
≈ $2.12 Million
-59.98%
2019-12-31 NT$168.21 Million
≈ $5.30 Million
+354.53%
2018-12-31 NT$37.01 Million
≈ $1.17 Million
-48.10%
2017-12-31 NT$71.31 Million
≈ $2.25 Million
-67.98%
2016-12-31 NT$222.74 Million
≈ $7.02 Million
-60.81%
2015-12-31 NT$568.28 Million
≈ $17.90 Million
-16.17%
2014-12-31 NT$677.92 Million
≈ $21.36 Million
-11.24%
2013-12-31 NT$763.76 Million
≈ $24.06 Million
+4.76%
2012-12-31 NT$729.07 Million
≈ $22.97 Million
+67.30%
2011-12-31 NT$435.79 Million
≈ $13.73 Million
+229.39%
2010-12-31 NT$132.30 Million
≈ $4.17 Million
+18.58%
2009-12-31 NT$111.57 Million
≈ $3.52 Million
-2.54%
2008-12-31 NT$114.48 Million
≈ $3.61 Million
+44.21%
2007-12-31 NT$79.39 Million
≈ $2.50 Million
+40.38%
2006-12-31 NT$56.55 Million
≈ $1.78 Million
-19.64%
2005-12-31 NT$70.37 Million
≈ $2.22 Million
-87.90%
2004-12-31 NT$581.48 Million
≈ $18.32 Million
-20.39%
2003-12-31 NT$730.38 Million
≈ $23.01 Million
--

About LIWANLI Innovation Co Ltd

TW:3054 Taiwan Drug Manufacturers - Specialty & Generic
Market Cap
$123.11 Million
NT$3.91 Billion TWD
Market Cap Rank
#18338 Global
#963 in Taiwan
Share Price
NT$48.45
Change (1 day)
+6.37%
52-Week Range
NT$22.30 - NT$90.30
All Time High
NT$90.30
About

LIWANLI Innovation Co., Ltd. operates in the biomedical science industry in Taiwan and internationally. The company offers Vigoway and powder collection products for male, female, elderly, and children. Its products include anti-aging desire, pro-active nutrients capsules, black elderberry powder, probiotic enzymes, oral care tablets, resveratrol red grape extract, algae DHA soft gels, shea butte… Read more